CGAT2 antibody market is projected to grow at a CAGR of 7.5% from 2023 to 2029. The growth in the market can be attributed to the increasing prevalence of CGAT2-positive diseases, rising demand for targeted therapies, and growing investments in R&D by biotechnology and pharmaceutical companies. The CGAT2 antibody market is segmented based on type […]
